Beacon Therapeutics raised $120M in Series A financing led by Syncona and investors including Oxford Science Enterprises (OSE) to develop ophthalmic cell therapies.
Amount Raised
$120 Million
Round Type
Series A
Investors
Description
British life science incubator Syncona has launched Beacon Therapeutics, a new gene therapy company focused on ophthalmic cell therapies, with the support of $120 million in Series A financing.
Quick answer
Beacon Therapeutics raised $120 Million in a Series A round, dated April 5, 2024. Investors: Oxford Science Enterprises and Syncona.
- How much did Beacon Therapeutics raise?
- Beacon Therapeutics raised $120 Million in a Series A round on April 5, 2024.
- Who invested in Beacon Therapeutics?
- Oxford Science Enterprises and Syncona are named as investors in this round.
- What does Beacon Therapeutics do?
- Beacon Therapeutics is a clinical-stage biotechnology company with a mission to save and restore the vision of patients with blinding retinal diseases.
- Where is Beacon Therapeutics based and how big is it?
- Fundz records about 91 employees.
- Who are the decision-makers at Beacon Therapeutics?
- Fundz holds 1 contact at Beacon Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Beacon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Kate Therapeutics raised $22M on May 17, 2024.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- Commit Biologics raised $17M (Seed) on May 10, 2024.
- BioVaxys Technology Corp. raised $52K on May 10, 2024.
- Zenas BioPharma raised $200M (Series C) on May 7, 2024.
- Nectin Therapeutics raised $10M (Private Equity) on May 6, 2024.
Who to call at Beacon Therapeutics, and when
A new round usually means Beacon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Beacon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beacon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beacon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBeacon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.